Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC# 57237-119-01
Published March 1, 2023 · Recall initiated: February 15, 2023
Summary
FDA records drug Class II recall D-0348-2023, published March 1, 2023 and initiated February 15, 2023. Recalling firm: RISING PHARMACEUTICALS; Status: Terminated; Reported quantity: 12,216 bottles (100 count each); Lot: Batch #: NB101596, Exp. 04/30/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- RISING PHARMACEUTICALS
- Distributor
- Product was distributed to 16 distributors and 8 wholesalers who may have further distributed the product nationwide.
- Lot
- Batch #: NB101596, Exp. 04/30/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDA0.9% Sodium Chloride Injection, USP, 500 mL Excel Plus Container, Rx Only, B. Braun Medical Inc. Bethlehem, PAMarch 1, 2023
- FDAGordon Choice Cranberry Orange Flavored Nut muffin batter; 8lbs; packaged in pailsMarch 1, 2023
- FDA0.9% Sodium Chloride Injection, USP, 1000 mL Excel Plus Container, Rx Only, B. Braun Medical Inc. Bethlehem,March 1, 2023
- FDAPilgrim's Roasted Nut'Z Chocolate Toffee Almonds are packaged by hand into either the 8 oz Plastic Cone BagsMarch 1, 2023
- FDAMethylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: RisingMarch 2, 2022
- FDAMeclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottle, Distributed by: Rising Pharma Holdings, Inc.October 13, 2021
Questions about this recall
Was Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC# 57237-119-01 recalled?
Yes. FDA published recall D-0348-2023 on March 1, 2023. Reported hazard: Failed Impurities/Degradation Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter